GI-MAP Allows for the Personalised Treatment Protocols and Informative Retests
Almost every patient can benefit from a GI-MAP gut health assessment. Some patients are looking to achieve optimal health, while other patients have been chronically ill and frustrated without a diagnosis for years.
Conditions where GI-MAP testing can support clinical diagnosis and protocol development include:
- Autoimmune diseases
- IBS/IBD
- Digestive complaints, diarrhoea or constipation
- Brain fog
- Inflammatory conditions
- Skin problems like acne and psoriasis
- Mood disorders, depression, and anxiety
- Diabetes and weight loss issues
GI Map
Overwhelmingly, research indicates that gut health impacts overall health. The gut microbiome, in particular, plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic and neuroendocrine functions.
Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness.
The GI-MAP (GI-Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusivelyon quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, and more, by targeting the specific DNA of the organisms tested.
